Temporal control of RAFT polymerization via magnetic catalysis
文献信息
Amin Reyhani, Masood S. Alivand, Kathryn A. Mumford, Greg Qiao
Magnetic core–shell structured catalysts, Fe3O4@Fe(II)–MOF nanoparticles (NPs), are synthesized in two steps including solvothermal synthesis of Fe3O4 NPs and self-assembly of Fe(II)–MOF particles on the core. They successfully enabled the real time and temporal control of an aqueous reversible addition–fragmentation chain transfer (RAFT) polymerization initiated by the Fenton reaction via an “on–off” reaction at room temperature. The Fenton reaction involves the reduction process of hydrogen peroxide (H2O2) by ferrous ions (Fe(II), inside the MOF), generating hydroxyl radicals (HO˙). These highly reactive radicals, therefore, initiate the magnetic Fenton-RAFT polymerization under ambient conditions. This process leads to the synthesis of controlled polymers with near quantitative monomer conversions, low dispersity values (Đ < 1.10), and experimental molecular weights in good agreement with the theoretical values. The versatility of this system in aqueous media is shown through the polymerization of acrylamide- and acrylate-type monomers including N-acryloylmorpholine, N,N-dimethylacrylamide, 2-hydroxyethyl acrylate, and poly(ethylene glycol) ethyl methyl acrylate, and the formation of polymers with different chain lengths. Moreover, the ‘living’ characteristics of the synthesized polymers are demonstrated with chain extension experiments and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-ToF) analysis. It is expected that the concept of magnetic catalysis could facilitate such temporal control (or “on–off” reaction) over a wide range of polymerizations from a ring opening polymerization (ROP) system where cobalt (or tin)-based catalysts are needed to an atom transfer radical polymerization (ATRP) method where Fe (or Cu)-based catalysts are required.
相关文献
Synthesis and biological evaluation of N6 derivatives of 8-azapurine as novel antiplatelet agents
Zhichang Zhao, Yeming Wang, Hong Yan, Juan Wang
DOI: 10.1039/D1MD00128K
Introducing the metacore concept for multi-target ligand design
Dagmar Stumpfe, Alexander Hoch, Jürgen Bajorath
DOI: 10.1039/D1MD00056J
Synthesis and structure–activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment
William L. Neumann, Karin E. Sandoval, Shirin Mobayen, Mahsa Minaeian, Stephen G. Kukielski, Khush N. Srabony, Rafael Frare, Olivia Slater, Susan A. Farr, Michael L. Niehoff, Audrey Hospital, Maria Kontoyianni, A. Michael Crider, Ken A. Witt
DOI: 10.1039/D1MD00044F
New prodrugs and analogs of the phenazine 5,10-dioxide natural products iodinin and myxin promote selective cytotoxicity towards human acute myeloid leukemia cells
Reidun Aesoy, Sindre Støa, Viola Lekve, Stein Ove Døskeland, Lars Herfindal, Pål Rongved
DOI: 10.1039/D1MD00020A
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties
Giselle de Andrade Ramos, Andressa Souza de Oliveira, Manuela Bartolini, Marina Naldi, Irene Liparulo, Christian Bergamini, Elisa Uliassi, Ling Wu, Paul E. Fraser, Monica Abreu, Alessandra Sofia Kiametis, Ricardo Gargano, Edilberto Rocha Silveira, Guilherme D. Brand, Lukas Prchal, Maria Laura Bolognesi, Luiz Antonio Soares Romeiro
DOI: 10.1039/D1MD00046B
Design, synthesis, crystal structure and anti-plasmodial evaluation of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives
Kavita Pal, Md Kausar Raza, Jenny Legac, Md. Ataur Rahman, Shoaib Manzoor, Philip J. Rosenthal, Nasimul Hoda
DOI: 10.1039/D1MD00038A
Recent advances in the development of covalent inhibitors
Hyunsoo Kim, Yoon Soo Hwang, Mingi Kim
DOI: 10.1039/D1MD00068C
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases
Feilong Zhou, Jin-Ming Yang
DOI: 10.1039/D0MD00361A
您可能还喜欢
什么是2-氨基戊烷(CAS号:63493-28-7)?
2-氨基戊烷,又名pentan-2-amine,是一种有机化合物,分子式为C5H11NH2。它是一种无色透明液体,有氨味。该化合物在工业和研究中有一定的应用。
反式-4-[4-[[[5-[(3,4-二氟苯基)氨基]-1,3,4-恶二唑-2-基]羰基]氨基]苯基]环己烷乙酸(CAS号:892489-52-0)的物理化学性质是什么?
该化合物为白色固体,分子量为552.31 g/mol。它在水中溶解度较低,在有机溶剂如乙腈、乙酸乙酯中有较好的溶解性。该化合物具有较高的化学稳定性,对酸和碱具有...
如何处理含有Pyrotinib dimaleate(CAS号:1397922-61-0)的废料?
处理含有Pyrotinib dimaleate 的废料时,应遵循当地的法规要求。首先,收集废料并进行分类,确保没有与其他化学品混合。然后,采取适当的物理和化学处...
在合成中是否有4-(5-5-乙基-1,2,4-噁二唑-3-基)苯甲酸乙酯(CAS号:1166756-79-1)的替代品?
在合成过程中,可以考虑使用其他结构类似的化合物作为替代品,例如苯甲酸酯类化合物,如2-乙基-5-甲基噁二唑基苯甲酸乙酯等。这些替代品可能具有相似的化学性质,但在...
如何处理含有1-((叔丁氧基羰基)氨基)环丁烷甲酸甲酯(CAS号:880166-10-9)的废料?
处理含有该化合物的废液时,应先确保其完全反应并转化为无害物质。对于未反应的化合物,建议采用中和处理后进行蒸馏回收,剩余物可使用化学氧化法或焚烧法进行无害化处理。...
2-({[3,5-二(三氟甲基)苯基]磺酰基}氨基)-4-(甲基硫代)丁酸甲酯(CAS号:175202-21-8)的市场或研究趋势如何?
目前该化合物主要应用于药物合成领域,尤其在开发新型抗癌药物方面具有潜在应用。随着制药行业的持续发展,对于高效、低毒的合成中间体需求增加,预计该化合物的研究和应用...
N,N-乙烯双(碘乙酰胺)(CAS号:7250-43-3)的物理化学性质是什么?
N,N-乙烯双(碘乙酰胺)是一种白色或类白色固体,易溶于乙醇、丙酮等有机溶剂,但在水中溶解度较低。该化合物具有较高的反应活性,可以与其他含有活性氢的化合物发生酰...
7-Fluoro-1H-spiro[furo[3,4-c]pyridine-3,4'-piperidine](CAS号:1283090-73-2)通常如何合成?
该化合物可以通过环合反应合成,首先合成吡啶和哌啶的衍生物,然后在合适的条件下进行环合反应得到目标化合物。常用的催化剂包括某些金属盐类,产率一般在70%-90%之...
处理3-乙酰滇乌碱(CAS号:80787-51-5)时应注意哪些实验室安全事项?
在处理3-乙酰滇乌碱时,应穿戴适当的个人防护装备(PPE),如实验服、手套(丁腈手套或PVC手套)、护目镜和口罩。实验应在通风橱中进行,以减少吸入或皮肤接触的风...
如何储存2-溴-5-硝基-4-羧酸(CAS号:1053655-82-5)?
2-溴-5-硝基-4-羧酸应存放在阴凉、干燥、通风良好的地方,远离火源和热源。避免与还原剂、碱性物质接触。储存容器应密封,防止吸湿。
来源期刊
Polymer Chemistry

Polymer Chemistry welcomes submissions in all areas of polymer science that have a strong focus on macromolecular chemistry. Manuscripts may cover a broad range of fields, yet no direct application focus is required.












![(3-{[4-(Aminomethyl)-6-(trifluoromethyl)-2-pyridinyl]oxy}phenyl)[(3R,4R)-3-fluoro-4-hydroxy-1-pyrrolidinyl]methanone structure (3-{[4-(Aminomethyl)-6-(trifluoromethyl)-2-pyridinyl]oxy}phenyl)[(3R,4R)-3-fluoro-4-hydroxy-1-pyrrolidinyl]methanone structure](https://cnstatic.chemtradehub.com/structs/200/2007885-39-2-affc.webp)
![Benzo[b]naphtho[2,1-d]thiophene structure Benzo[b]naphtho[2,1-d]thiophene structure](https://cnstatic.chemtradehub.com/structs/239/239-35-0-ff90.webp)
